Massmann A - Search Results

1

Attitudes about pharmacogenomic testing vary by healthcare specialty.

Preys CL, Blout Zawatsky CL, Massmann A, Heukelom JV, Green RC, Hajek C, Hickingbotham MR, Zoltick ES, Schultz A, Christensen KD. Preys CL, et al. Among authors: massmann a. Pharmacogenomics. 2023 Jul;24(10):539-549. doi: 10.2217/pgs-2023-0039. Epub 2023 Jul 17. Pharmacogenomics. 2023. PMID: 37458095 Free PMC article.

2

Implementation of wide-scale pharmacogenetic testing in primary care.

Natasha Petry, Baye J, Aifaoui A, Wilke RA, Lupu RA, Savageau J, Gapp B, Massmann A, Hahn D, Hajek C, Schultz A. Natasha Petry, et al. Among authors: massmann a. Pharmacogenomics. 2019 Aug;20(12):903-913. doi: 10.2217/pgs-2019-0043. Pharmacogenomics. 2019. PMID: 31453774

3

Malignant hyperthermia susceptibility: utilization of genetic results in an electronic medical record to increase safety.

Baye JF, Petry NJ, Jacobson SL, Moore MM, Tucker B, Shaaban S, Massmann AK, Clark NM, Schultz AJ. Baye JF, et al. Pharmacogenomics. 2020 Nov;21(17):1207-1215. doi: 10.2217/pgs-2020-0088. Epub 2020 Oct 29. Pharmacogenomics. 2020. PMID: 33118445

4

Improved provider preparedness through an 8-part genetics and genomic education program.

Hajek C, Hutchinson AM, Galbraith LN, Green RC, Murray MF, Petry N, Preys CL, Zawatsky CLB, Zoltick ES, Christensen KD; Imagenetics METRICS Team. Hajek C, et al. Genet Med. 2022 Jan;24(1):214-224. doi: 10.1016/j.gim.2021.08.008. Epub 2021 Nov 30. Genet Med. 2022. PMID: 34906462 Free PMC article.

5

Progression of precision statin prescribing for reduction of statin-associated muscle symptoms.

Petry NJ, Baye JF, Frear S, Jacobsen K, Massmann A, Schultz A, Heukelom JV, Christensen K. Petry NJ, et al. Among authors: massmann a. Pharmacogenomics. 2022 Jul;23(10):585-596. doi: 10.2217/pgs-2022-0055. Epub 2022 Jul 1. Pharmacogenomics. 2022. PMID: 35775396 Review.

6

Leveraging clinical decision support to reduce the risk of discordant pharmacogenomics results.

Massmann A, Heukelom JV, Larson C, Starks RD. Massmann A, et al. Pharmacogenomics. 2022 Dec;23(18):987-993. doi: 10.2217/pgs-2022-0148. Epub 2022 Dec 1. Pharmacogenomics. 2022. PMID: 36454237 Review.

7

Metoprolol and CYP2D6: A Retrospective Cohort Study Evaluating Genotype-Based Outcomes.

Collett S, Massmann A, Petry NJ, Van Heukelom J, Schultz A, Hellwig T, Baye JF. Collett S, et al. Among authors: massmann a. J Pers Med. 2023 Feb 26;13(3):416. doi: 10.3390/jpm13030416. J Pers Med. 2023. PMID: 36983598 Free PMC article.

8

Patient satisfaction with return of pharmacogenomic results utilizing a patient portal message.

Heukelom JV, Jacobsen K, Petry NJ, Schultz A, Baye J, Sturdevant D, Massmann A. Heukelom JV, et al. Among authors: massmann a. Pharmacogenomics. 2023 Apr;24(6):315-323. doi: 10.2217/pgs-2023-0032. Epub 2023 Apr 26. Pharmacogenomics. 2023. PMID: 37125619 Free PMC article.

9

SLCO1B1 gene-based clinical decision support reduces statin-associated muscle symptoms risk with simvastatin.

Massmann A, Van Heukelom J, Green RC, Hajek C, Hickingbotham MR, Larson EA, Lu CY, Wu AC, Zoltick ES, Christensen KD, Schultz A. Massmann A, et al. Pharmacogenomics. 2023 May;24(7):399-409. doi: 10.2217/pgs-2023-0056. Epub 2023 May 26. Pharmacogenomics. 2023. PMID: 37232094 Free PMC article.

10

Congruence rates for pharmacogenomic noninterruptive alerts.

Mills SC, Massmann A. Mills SC, et al. Among authors: massmann a. Pharmacogenomics. 2023 Jun;24(9):493-500. doi: 10.2217/pgs-2023-0016. Epub 2023 Jul 12. Pharmacogenomics. 2023. PMID: 37435734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters